Potential Effect of Anti-Inflammatory Treatment on Reducing the Cardiovascular Risk in Rheumatoid Arthritis

By  

Current Vascular Pharmacology, Vol. 10, Iss. 5, 2012-09 ,pp. : 639-646

Bentham Science Publishers

Access to resources Recommend Favorite

Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis

By Hishitani Y   Ogata A   Shima Y   Hirano T   Ebina K   Kunugiza Y   Shi K   Narazaki M   Hagihara K   Tomita T   Yoshikawa H   Tanaka T   Kumanogoh A  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. : 253-259

Informa Healthcare

Access to resources Recommend Favorite

Change in Gait Deviation Index after anti-tumour necrosis factor-α treatment in individuals with rheumatoid arthritis: a pilot study

By Broström EW   Esbjörnsson A-C   Heideken J von   Larsson P   Wretenberg P   Iversen M  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 5, 2013-10 ,pp. : 356-361

Informa Healthcare

Access to resources Recommend Favorite

Individual medicine in inflammatory bowel disease: Monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

By Bendtzen Klaus   Ainsworth Mark   Steenholdt Casper   Thomsen Ole Østergaard   Brynskov Jørn  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 7, 2009-07 ,pp. : 774-781

Informa Healthcare

Access to resources Recommend Favorite

Tumour necrosis factor-alpha inhibitor-induced hepatic injury in patients with rheumatoid arthritis: two case reports and an analysis of the laboratory data from the Slovenian national biologicals registry

By Perdan-Pirkmajer Katja   Hočevar Alojzija   Rotar Žiga   Žibert Janez   Marolt Vera   Gučev Filip   Tomšič Matija  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2885-2888

Springer Publishing Company

Access to resources Recommend Favorite